Perrigo | PRGO - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
AbbVie USD 3.89B 325M 2025-12
Abbott USD 3.27B 138M 2026-03
Bayer EUR 4.05B 647M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Coherus Biosciences USD 15M 6.26M 2025-12
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Dr.Reddys Laboratories INR 26.92B 482M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
J&J USD 6.03B 719M 2026-03
Merck USD 2.85B 215M 2025-12
Nestle CHF 12.46B 267M 2025-12
Pacira USD 91.87M 70K 2025-12
Perrigo USD 255.9M 10.2M 2025-12
Pfizer USD 4.08B 894M 2025-12
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Sanofi EUR 2.33B 419M 2026-03
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Zoetis USD 619M 40M 2025-12